logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hossein Taghizadeh

Shiraz University
H指数:11
被引数:412

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study

三氟尿idine/替吡拉塞联合贝伐珠单抗与三氟尿idine/替吡拉塞或瑞戈非尼治疗转移性结直肠癌的临床结局：一项多中心队列研究

ESMO Open
IF8.3
2026-03-260
OAAI
F. Moik; F. Huemer; B. Doleschal; H. Taghizadeh; P. Reimann; S.M. Kostmann; L. Wagner; M. Abdel Hamid; K.C. Zimmer; S.A. Suppé; C. Bachleitner; R. Schaberl-Moser; A. Amann; D. Wolf; R. Greil; P.J. Jost; T. Winder; H. Rumpold; L. Weiss; A. Gerger
AGMT mCRC Registry Third-Line and Beyond: a multicentric real-world platform with integrated imaging and biosample database for later-line metastatic colorectal cancer

AGMT mCRC注册研究：第三线及以后治疗——一个整合影像和生物样本数据库的多中心真实世界平台，用于晚期转移性结直肠癌

Future Oncology
IF2.6
2026-03-010
PRE
Huemer, Florian; Piringer, Gudrun; Eisterer, Wolfgang; Heibl, Sonja; Rumpold, Holger; Woll, Ewald; Schreil, Georg; Sliwa, Thamer; Winder, Thomas; Prager, Gerald; Grunberger, Birgit; Moik, Florian; Amann, Arno; Taghizadeh, Hossein; Niedersuss-Beke, Dora; Greil, Richard; Weiss, Lukas
Clinical practice and implications of biomarker testing in biliary tract cancer: an observational study☆

胆道癌中生物标志物检测的临床实践与意义：一项观察性研究☆

JHEP Reports
IF7.5
2025-11-040
OAAI
Sabrina Welland; Ann-Kristin Zöller; Ilektra A. Mavroeidi; Aurelie Tomczak; Christian Müller; Dong Yawen; Danmei Zhang; Felix Keil; Maria Pangerl; Taotao Zhou; Hossein Taghizadeh; Sebastian Lange; Maximilian N. Kinzler; Kataryna Shmanko; Maryam Barsch; Carolin Zimpel; Angela Djanani; Henning Schulze-Bergkamen; Julius Keyl; Florian Lüke; Thomas Wirth; Michael Dill; Thomas Longerich; Sophia Petschnak; Jens U. Marquardt; Michael Quante; Arndt Weinmann; Dirk Walter; Nicole Pfarr; Gerald Prager; Bernhard Doleschal; Maria A. Gonzalez-Carmona; Rainer Günther; Alexander Scheiter; Stefan Böck; Stephan Bartels; Thomas Gruenberger; Marino Venerito; Christoph Springfeld; Stefan Kasper; Anna Saborowski; Arndt Vogel
Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis

恩福妥单抗 vedotin 联合帕博利珠单抗治疗初治转移性尿路上皮癌患者：一项奥地利真实世界分析

International Journal of Cancer
IF4.7
2025-10-220
OAAI
Dora Niedersuess-Beke; Karl Mayrhofer; Johanna Krauter; Johannes Franke; Dominic Vais; Maximillian Pallauf; David Kiesl; Ferdinand Luger; Jacob Pfuner; Angelika Terbuch; Thomas Bauernhofer; Jasmin Spielgelberg; Andreas Banner; Stefan Aufderklamm; Clemens Wiesinger; Susanne Schnabel; Simon Peter Gampenrieder; Josef Mühlmann; Sonia Vallet; Sabine Weibrecht; Franz Stoiber; Haleh Andalibi; Harun Fajkovic; Hossein Taghizadeh; Jan Miechowiecki; Roman Taedcke; Daniel Heintel; Shahrokh F. Shariat; Martin Pichler; Wolfgang Hilbe; Renate Pichler
Real-world effectiveness and predictive biomarker analysis of TAS-102+bevacizumab vs. regorafenib vs. TAS-102 in metastatic colorectal cancer: A multicenter cohort study

TAS-102+bevacizumab对比regorafenib对比TAS-102在转移性结直肠癌中的真实世界有效性与预测性生物标志物分析：一项多中心队列研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Seeber, A.; Huemer, F.; Doleschal, B.; Taghizadeh, H.; Reimann, P.; Moik, F.; Kostmann, S.; Wagner, L.; Granitzer, J.; Hamid, M. Abdel; Bachleitner, C.; Amann, A.; Wolf, D.; Greil, R.; Jost, P. J.; Winder, T.; Rumpold, H.; Weiss, L.; Gerger, A.; Riedl, J. M.
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity
ESMO OPEN
IF8.3
2024-08-012
OAAI
Mavroeidi, I. A.; Burghofer, J.; Kalbourtzis, S.; Taghizadeh, H.; Webersinke, G.; Piringer, G.; Kasper, S.; Schreil, G.; Liffers, S. T.; Reichinger, A.; Kirchweger, P.; Heibl, S.; Hamacher, R.; Schmitt, C. A.; Schuler, M.; Prager, G. W.; Kersting, D.; Treckmann, J.; Schildhaus, H. -U; Rumpold, H.; Siveke, J. T.; Doleschal, B.
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI

治疗难治性实体瘤的靶向治疗建议-来自真实世界精准医学平台MONDTI的数据

JOURNAL OF PERSONALIZED MEDICINE
IF3
2020-10-237
OAAI
Taghizadeh, Hossein; Unseld, Matthias; Spalt, Martina; Mader, Robert M.; Mullauer, Leonhard; Fuereder, Thorsten; Raderer, Markus; Sibilia, Maria; Hoda, Mir Alireza; Aust, Stefanie; Polterauer, Stephan; Lamm, Wolfgang; Bartsch, Rupert; Preusser, Matthias; Kautzky-Willer, A.; Prager, Gerald W.

研究方向

暂未获取到该数据
G
Gerald W. Prager
H 指数:44论文数:393被引数:6,718
R
Robert M. Mader
H 指数:41论文数:422被引数:5,380
M
Muellauer, L.
H 指数:0论文数:18被引数:0
B
Bernhard Doleschal
H 指数:11论文数:46被引数:635
H
Holger Rumpold
H 指数:32论文数:146被引数:4,833
M
Matthias Preusser
H 指数:96论文数:1,140被引数:4.3万
P
Patrick Kirchweger
H 指数:11论文数:47被引数:433
G
Gerald Webersinke
H 指数:20论文数:86被引数:1,453
T
Thomas Gruenberger
H 指数:54论文数:326被引数:1.8万
T
Thomas Winder
H 指数:34论文数:192被引数:4,061